Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 22, 2002

View Archived Issues

A possible role for the Rho kinase-mediated signaling pathway in asthma

R-115777 radiosensitizes previously radioresistant human glioma cells

Successful treatment of severe alcoholic hepatitis with urinastarine

Modafinil improves symptoms in children with spastic cerebral palsy

Y-931 is less sensitive to oxidative phenomena than other antipsychotics

ZYC-101a shows potential in the treatment of anal dysplasia

KF-26777 may be useful in the treatment of brain ischemia

Sanofi-Synthelabo describes new agent for the treatment of AD

Diovan receives approval as heart failure therapy in U.S.

Abbott describes novel alphavbeta3 receptor modulators with potential in cardiovascular disorders

New antiprotozoal compounds prepared and tested by Akzo Nobel researchers

Selective thrombin inhibitors identified by LEK and University of Ljubljana researchers

Rambaxy identifies novel antifungal compounds

Phase III study of Antisoma's pemtumomab expected to be completed in 2004

Schering AG in-licenses further rights to fasudil

Vernalis to report findings from frovatriptan menstrual migraine trial next month

Aventis seeking U.S. marketing approval for Ketek

Potassium channel openers for use in bladder overactivity presented by Abbott at ACS

Early clinical data discussed for the adenosine A1 antagonist BG-9928

Discovery of novel PPARalpha agonists and selection of a clinical candidate

Discovery and synthesis of the clinical candidate CP-608039 reported at ACS

Millennium reports SAR studies on melanocortin MC-4 antagonists

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...